Search Results
Found 22 results for "Data Integrity" across articles, medicines, trials, companies and the glossary
Industry
US Pharma Resume Guide 2026: FDA cGMP Standards, ATS Formats & Free Builder
Master the US pharmaceutical resume format in 2026. Covers FDA 21 CFR compliance terms, 1-2 page US resume rules, major US biopharma hubs (Boston, SF Bay, NJ, NC Triangle), and free ATS resume tools.
Industry
Master the Ireland & EU Pharma CV in 2026: HPRA Standards, ATS Templates & Industry Examples
The definitive 2026 guide to writing an ATS-compliant biopharmaceutical CV in Ireland and the EU. Features HPRA & EU Annex 1 standards, GxP bullet point formulas, Irish regional hub insights, and free ATS CV Studio tools.
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
Regulatory Affairs
Data Integrity and Quality Oversight: Analyzing the FDA Warning Letter for Sanofi's Waterford Site
Following a January 2026 inspection, the FDA has issued a formal warning letter to Genzyme Ireland Limited in Waterford, citing data integrity concerns, uncontrolled checklists, and quality unit oversight gaps in the manufacturing of Thymoglobulin and Altuviiio.
Regulatory Affairs
The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026
A comprehensive technical report detailing the top 10 trends in Good Manufacturing Practice (GMP), sterile manufacturing, GAMP 5, Quality 4.0, and continuous manufacturing currently reshaping the global pharmaceutical landscape.
Regulatory Affairs
FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
The FDA has issued a formal warning letter to Sanofi's Waterford facility, Genzyme Ireland Limited, citing data integrity breaches, discarded quality records, and botched deviation investigations in the production of haemophilia drug Altuviiio and transplant therapy Thymoglobulin.
Regulatory Affairs
Data Integrity in the Pharmaceutical Quality Control Laboratory: ALCOA+ Principles Explained
An educational review of data integrity requirements in pharma QC, covering ALCOA+ principles, audit trails, and data security.
Regulatory Affairs
Computer Systems Validation (CSV): Implementing the GAMP 5 Lifecycle Framework in Modern Plants
A guide to validating computerized lab and production systems using the GAMP 5 V-model lifecycle, risk assessments, and electronic records compliance.
MedTech
From Pilots to Infrastructure: How AI is Becoming the Core Operating System for Biopharma R&D in 2026
Artificial intelligence has evolved from sandbox pilot projects to become the default operating system driving drug discovery, clinical trials, and sterile manufacturing.
Biotechnology
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
LinkedIn
LinkedIn PR for Life Science & Pharma: The Definitive Guide to Building Credibility, Authority, and Visibility in 2026
A practitioner-level guide to building genuine professional authority on LinkedIn as a pharmaceutical, biotech, or MedTech professional. Covers profile architecture, content strategy, engagement tactics, thought leadership frameworks, and the exact playbooks used by the most followed life science voices on the platform.
Regulatory Affairs
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.
MedTech
Leading Digital Transformation in Ireland’s Pharma Sector: 5 Ways to Overcome Middle Management Resistance to AI
As Ireland’s pharma sector pivots toward Industry 4.0, middle management resistance to AI is a critical bottleneck. Here are 5 root causes of this pushback and targeted strategies to align your teams and drive digital transformation.
MedTech
EU-India FTA: A New Era of Trade Creating a 2 Billion People Free Trade Zone
Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.
MedTech
Resilient MedTech Ecosystems: Localized Value Chains and Shared Infrastructure in Ireland's Medical Device Clusters (2026)
An analytical review of how local manufacturing clusters and medical device parks in Galway, Limerick, and Athlone are mitigating global supply chain risks. We examine the shared infrastructure model for prototyping and calibration, and the integration of client-side validation tools like Priya LifePDF.
Pharmaceutical
From Powerhouse to Pioneer: How Ireland's Life Science Sector Is Pivoting from Manufacturing to an R&D-Led Innovation Hub in 2026
An in-depth analysis of Ireland's National Life Science Innovation Strategy in 2026. We examine the structural challenges of this transition-including specialised R&D infrastructure, the acute talent shortage in cell and gene therapies (CGT), and how digital compliance tools like Priya LifePDF streamline the transition.
MedTech
The Digital-First Regulatory Landscape: How Ireland's Life Science Sector Is Adapting to the EU AI Act, EHDS, and Governance by Design
A comprehensive guide for Irish pharmaceutical, MedTech, and life science professionals on the EU AI Act implementation, the European Health Data Space, cGMP compliance in an AI-driven environment, ALCOA+ in digital systems, and the practical steps organisations must take to achieve governance by design in 2026.
Regulatory Affairs
Democratizing Pharma Compliance: How Priya LifeScience is Empowering Ireland's Biotech and Pharmaceutical Sectors with Free, Open-Source, and 100% Private Digital Utilities
Priya LifeScience is on a mission to democratize compliance, quality assurance, and documentation in Ireland's pharmaceutical and biotech sectors by providing 100% free, open-source, browser-native digital utilities.
Regulatory Affairs
EU GMP Annex 1 in 2026: What Every Sterile Manufacturing Professional in Ireland Must Know
The revised EU GMP Annex 1 is fully enforced. If you work in sterile pharma manufacturing in Ireland, here are the key changes, what HPRA inspectors are checking, and how to prepare your CV.
Industry
How to Get Your First Pharma Job in Ireland in 2026: The Complete Step-by-Step Guide
A practical, no-nonsense guide for science graduates and career changers looking to break into Ireland's world-class pharmaceutical and MedTech sector in 2026.
LinkedIn
How to Set Up Your LinkedIn Profile for Pharma Jobs in Ireland
Optimize your LinkedIn profile with pharma specific keywords, skills, and Ireland-focused positioning to increase visibility and attract recruiter opportunities.